Mesa Laboratories (MLAB) Narrows Q4 Loss as Revenue Climbs 8%

On May 27, 2026, Mesa Laboratories Inc. (NASDAQ: MLAB) reported a fiscal fourth-quarter net loss of $1.2 million, or $0.24 per share, narrowing from a loss of $3.4 million, or $0.68 per share, a year earlier. Revenue rose 8% to $52.3 million, driven by increased orders for its quality control instruments and consumables used in pharmaceutical and healthcare industries. Excluding one-time items, the adjusted loss was $0.15 per share. The Lakewood, Colorado-based company said operational efficiencies and lower restructuring costs contributed to the improved bottom line.